Advanced search

Authors whose works are in public domain in at least one jurisdiction

List of works by Mario Scartozzi

51-100 of 126 results

Lactate Dehydrogenase in Hepatocellular Carcinoma: Something Old, Something New

scientific article

Clinical predictive factors for advanced non-small cell lung cancer (NSCLC) patients receiving third-line therapy: Selecting the unselectable?

scientific article published on 6 August 2009

The correlation between LDH serum levels and clinical outcome in advanced biliary tract cancer patients treated with first line chemotherapy.

scientific article published on 11 April 2016

Angiogenesis genotyping in the selection of first-line treatment with either sunitinib or pazopanib for advanced renal cell carcinoma.

scientific article published on 09 May 2016

Tumor infiltrating lymphocytes in gastrointestinal tumors: Controversies and future clinical implications

scientific article published on 25 November 2016

Mismatch repair system (MMR) status correlates with response and survival in non-small cell lung cancer (NSCLC) patients

scientific article published in July 2006

The response of breast cancer cells to mesenchymal stem cells: a possible role of inflammation by breast implants.

scientific article published on December 2013

Angiogenesis genotyping and clinical outcome during regorafenib treatment in metastatic colorectal cancer patients.

scientific article published on 27 April 2016

Survival in patients with clear cell renal cell carcinoma is predicted by HIF-1α expression.

scientific article published on January 2015

Predictive and prognostic role of E-cadherin protein expression in patients with advanced gastric carcinomas treated with palliative chemotherapy.

scientific article published in May 2004

Pegylated liposomal doxorubicin, 5-fluorouracil and cisplatin versus mitomycin-C, 5-fluorouracil and cisplatin for advanced gastric cancer: a randomized phase II trial

scientific article

Prognostic factors in 868 advanced gastric cancer patients treated with second-line chemotherapy in the real world.

scientific article published on 27 December 2016

Role of vascular endothelial growth factor (VEGF) and VEGF-R genotyping in guiding the metastatic process in pT4a resected gastric cancer patients

scientific article

Clinical evidence for three distinct gastric cancer subtypes: time for a new approach

scientific article

Prognostic Value for Incidental Antihypertensive Therapy With β-Blockers in Metastatic Colorectal Cancer.

scientific article

Allele polymorphisms of tumor integrins correlate with peritoneal carcinosis capability of gastric cancer cells in radically resected patients

scientific article published on 06 October 2010

Treatment sequence with either irinotecan/cetuximab followed by FOLFOX-4 or the reverse strategy in metastatic colorectal cancer patients progressing after first-line FOLFIRI/bevacizumab: An Italian Group for the Study of Gastrointestinal Cancer pha

scientific article published on 20 July 2017

Three drugs vs two drugs first-line chemotherapy regimen in advanced gastric cancer patients: a retrospective analysis.

scientific article published on December 2015

Elderly patients with advanced non-small cell lung cancer. A pase II study with weekly cisplatin and gemcitabine

scientific article

Epidermal growth factor receptor (EGFR) downstream signalling pathway in primary colorectal tumours and related metastatic sites: optimising EGFR-targeted treatment options.

scientific article published on 19 June 2007

The Immune Revolution in Gastrointestinal Tumours: Leading the Way or Just Following?

scientific article published on 17 May 2016

Over-DI dissection may question the value of radiotherapy as a part of an adjuvant programme in high-risk radically resected gastric cancer patients.

scientific article published on March 2005

Outcomes of Advanced Gastric Cancer Patients Treated with at Least Three Lines of Systemic Chemotherapy.

scientific article published on 31 August 2017

Second-line angiogenesis inhibition in metastatic colorectal cancer patients: Straightforward or overcrowded?

scientific article published on 12 February 2016

Beyond RAS: the role of epidermal growth factor receptor (EGFR) and its network in the prediction of clinical outcome during anti-EGFR treatment in colorectal cancer patients

scientific article

The role of primary tumour sidedness, EGFR gene copy number and EGFR promoter methylation in RAS/BRAF wild-type colorectal cancer patients receiving irinotecan/cetuximab.

scientific article published on 20 June 2017

Selected gastrointestinal cancer presentations from the American Society of Clinical Oncology annual meeting 2013 in review: it is not about the destination, it is about the journey

scientific article

First-line FOLFIRI and bevacizumab in patients with advanced colorectal cancer prospectively stratified according to serum LDH: final results of the GISCAD (Italian Group for the Study of Digestive Tract Cancers) CENTRAL (ColorEctalavastiNTRiAlLdh)

scientific article published on 19 September 2017

The Role of Aspirin as Antitumoral Agent for Heavily Pretreated Patients With Metastatic Colorectal Cancer Receiving Capecitabine Monotherapy

scientific article published on 04 August 2016

New target therapies in advanced pancreatic cancer.

scientific article published on May 2006

Off-target effects and clinical outcome in metastatic colorectal cancer patients receiving regorafenib: The TRIBUTE analysis

scientific article published on 05 April 2017

Recent aspects of sunitinib therapy in patients with metastatic clear-cell renal cell carcinoma: a systematic review of the literature

scientific article

State of the art and future perspectives for the use of insulin-like growth factor receptor 1 (IGF-1R) targeted treatment strategies in solid tumors

scientific article published on February 1, 2011

Role of β4 integrin in HER-3-negative, K-RAS wild-type metastatic colorectal tumors receiving cetuximab

scientific article

Outcomes of Advanced Gastric Cancer Patients Treated with at Least Three Lines of Systemic Chemotherapy

scientific article published in February 2018

Locoregional treatments of unresectable liver metastases from colorectal cancer

scientific article published on 01 February 1998

Tumor VEGF expression correlates with tumor stage and identifies prognostically different groups in patients with clear cell renal cell carcinoma

scientific article

The role of 5-fluorouracil (5-FU) reintroduction with irinotecan or oxaliplatin in truly 5-FU-refractory advanced colorectal cancer patients

scientific article published on 7 July 2005

Tracking the 2015 Gastrointestinal Cancers Symposium: bridging cancer biology to clinical gastrointestinal oncology

scientific article

Multidisciplinary treatment of locally advanced rectal cancer: a literature review. Part 1.

scientific article published on October 2009

Molecular biology for stage II colorectal cancer: the jury is still out

scientific article published on 01 July 2007

Role and mechanisms of resistance of epidermal growth factor receptor antagonists in the treatment of colorectal cancer.

scientific article published on 04 June 2015

Locally advanced rectal cancer: from molecular profiling to clinical practice. A literature review: Part 2.

scientific article published on October 2009

Prognostic Value of Thyroid Hormone Ratios in Patients With Advanced Metastatic Colorectal Cancer Treated With Regorafenib: The TOREADOR Study

scientific article published on 08 June 2018

The distinctive molecular, pathological and clinical characteristics of BRAF-mutant colorectal tumors

scientific article published on 15 May 2015

Phase II study of pharmacogenetic-tailored therapy in elderly colorectal cancer patients

scientific article published on 03 September 2011

Anti-EGFR strategies as an incremental step for the treatment of colorectal cancer patients: moving from scientific evidence to clinical practice.

scientific article

The timing of surgery for resectable metachronous liver metastases from colorectal cancer: Better sooner than later? A retrospective analysis

scientific article published on 21 August 2010

Steps Ahead in the Treatment of Advanced Colorectal Cancer: Past, Current and Possible Future Scenarios

scientific article published on September 11, 2015

Pharmacogenomics of cetuximab in metastatic colorectal carcinoma.

scientific article